NIMESID Tablet is an effective analgesic and anti-inflammatory medication developed to manage pain, inflammation, and fever across a wide range of medical conditions. Each tablet contains Nimesulide, a selective COX-2 inhibitor that helps block the production of prostaglandins responsible for inflammation and pain response. NIMESID offers quick relief with a favorable safety profile when used appropriately and for short durations.
The formulation is particularly effective in managing acute inflammatory conditions such as joint pain, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-operative pain, and menstrual cramps. Its pharmacodynamic action provides both symptomatic and therapeutic benefits, reducing inflammation at the site of pain while also lowering body temperature when fever is present.
Manufactured by Bluepill Express, NIMESID Tablet is produced in state-of-the-art WHO-GMP-compliant facilities, ensuring consistent quality and adherence to international regulatory requirements. From sourcing of raw materials to final packaging, each step in the manufacturing process is closely monitored to ensure that the finished product meets global standards.
NIMESID Tablet acts quickly—often within 30 minutes—providing rapid pain relief and increased comfort for patients. Its action is more targeted compared to traditional NSAIDs, reducing the risk of gastrointestinal side effects associated with non-selective COX inhibition. However, like all NSAIDs, it should be taken with caution in individuals with a history of gastric ulcers, liver impairment, or NSAID hypersensitivity.
Bluepill Express offers NIMESID in tamper-proof blister packaging for retail distribution and in export-optimized formats for bulk or institutional sales. The tablet is film-coated to improve swallowability and reduce gastric discomfort. All batches undergo strict quality testing including dissolution profile analysis, microbial testing, and stability testing across various climatic zones.
As a trusted third-party manufacturer and exporter, Bluepill Express provides all supporting technical documents including Certificate of Analysis (COA), Product Dossiers, MSDS, and marketing authorization support upon request. Private labeling options are also available to meet branding needs of global partners.
NIMESID Tablet is recommended for adult patients and should be prescribed for short-term use under medical supervision. Long-term or unsupervised usage is discouraged due to potential hepatotoxicity, a known risk associated with prolonged use of Nimesulide. The product is not recommended for children under 12 years, pregnant or lactating women, or individuals with known hepatic conditions.
Description provided by bluepill express.
FIEO Registered
Export Ready
